Health TrialsbyHealthPanel

The Family Talk Intervention When a Parent With Dependent Children or a Child is Severely Ill

ConditionIllness Terminal
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6+
SponsorErsta Sköndal University College

About this trial

The overall aim of this study is to evaluate the effects and the implementation process of the Family Talk Intervention (FTI) in clinical practice when a child or a parent of dependent children has a life-threatening/life-limiting illness (cancer, neurological diseases, etc.). During 2021, FTI will be implemented in several different care contexts including a children's hospital and a university hospital in Sweden. Social workers will be educated in using the FTI in their clinical work. This study has a pre-post effectiveness-implementation hybrid design using mixed method. Data collection will be made using web-based questionnaires and interviews with families and social workers, and observations will be performed throughout the study.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Families that include a child with a life-threatening/life-limiting illness.

2-3 months should have passed since diagnosis or relapse.

<2 members of the family need to participate

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

  • Family Talk Intervention

    Other intervention

    A psychosocial family-based intervention that is designed to give support to an entire family when a child has life-threatening illness.

Treatment groups

150 Participants
are divided into 1 treatment group
Group A: Family Talk interventionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Changed family communication from Family Adaptability and Cohesion Scale IV (FACES IV)

Measures family communication

Time frame
At baseline (before FTI starts), after the end of FTI/three months later (follow-up 1), and six months after that (follow-up 2).

Secondary outcomes

1

Changed resilience for adults measured by the Resilience Scale (RS-14)

Measures psychosocial health for parents/guardians and for children aged 13 years and older

Time frame
At baseline (before FTI starts), after the end of FTI/three months later (follow-up 1), and six months after that (follow-up 2).
2

Changed resilience in children measured by the Resilience Scale for Children (RS-10),

Measures psychosocial health for children aged 8-12 years

Time frame
At baseline (before FTI starts), after the end of FTI/three months later (follow-up 1), and six months after that (follow-up 2).
3

Changed symptoms of pathologic grief measured by Prolonged Grief Disorder (PG-12)

Measures pre-death grief

Time frame
At baseline (before FTI starts), after the end of FTI/three months later (follow-up 1), and six months after that (follow-up 2).
4

Generalized Anxiety Disorder (GAD)

Measures anxiety in adults

Time frame
At baseline (before FTI starts), after the end of FTI/three months later (follow-up 1), and six months after that (follow-up 2).

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Ersta Sköndal University College

Lead sponsor

Source ClinicalTrials.gov
Apply now